Last deal

$4.3M

Amount

Venture - Series Unknown

Stage

15.11.2019

Date

4

all rounds

$13.3M

Total amount

General

About Company
IRIS provides cloud-based retinal screening to diagnose early stages of eye disease in diabetic patients.

Industry

Sector :

Subsector :

Keywords :

Also Known As

IRIS

founded date

01.01.2011

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

IRIS offers retinal imaging systems that integrate with any EMR platform, providing a seamless diagnostic solution for non-traditional eyecare settings. Founded in 2011, IRIS partners with providers and payers to enhance patient outcomes and has received multiple awards for its innovation in diabetic retinopathy detection.
Contacts